ATRA
Showing 1 - 25 of 161
Acute Myeloid Leukemia Trial in Suzhou (Azacitidine Combined With Venetoclax and ATRA group)
Recruiting
- Acute Myeloid Leukemia
- Azacitidine Combined With Venetoclax and ATRA group
-
Suzhou, Chinathe First Affiliated Hospital of Soochow University
Dec 8, 2022
Prostatic Tumors, Prostate Tumors, Prostate Cancer Trial in New York (5-Azacitidine, all trans retinoic acid, Lupron)
Completed
- Prostatic Neoplasms
- +2 more
- 5-Azacitidine
- +2 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Aug 1, 2022
Multiple Myeloma Trial in Amsterdam (all-trans retinoic acid (ATRA))
Active, not recruiting
- Multiple Myeloma
- all-trans retinoic acid (ATRA)
-
Amsterdam, NH, NetherlandsVU University Medical Center
May 5, 2022
Glioma, IDH Mutation, Astrocytoma Trial in Philadelphia (Retifanlimab, All-trans retinoic acid)
Not yet recruiting
- Glioma
- +3 more
- Retifanlimab
- All-trans retinoic acid
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Jul 22, 2022
Colorectal Cancer Trial (all trans Retinoic Acid, Atezolizumab, Bevacizumab)
Not yet recruiting
- Colorectal Cancer
- all trans Retinoic Acid
- +2 more
- (no location specified)
Aug 11, 2023
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Adelaide (IMG-7289, All-trans retinoic acid)
Completed
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- IMG-7289
- All-trans retinoic acid
-
Adelaide, South Australia, AustraliaRoyal Adelaide Hospital
Jan 24, 2022
Melanoma Trial in Aurora (VESANOID, Ipilimumab)
Active, not recruiting
- Melanoma
-
Aurora, ColoradoUniversity of Colorado Hospital
Sep 7, 2022
Acute Myeloid Leukemia Trial in Xi'an (All-trans retinoic acid, Arsenic Trioxide, Realgar-Indigo naturalis formula)
Recruiting
- Acute Myeloid Leukemia
- All-trans retinoic acid
- +2 more
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xi'an Jiaotong University
Mar 23, 2022
Purpura, Thrombocytopenic, Idiopathic Trial in Beijing (all-trans retinoic acid, Eltrombopag)
Not yet recruiting
- Purpura, Thrombocytopenic, Idiopathic
- all-trans retinoic acid
- Eltrombopag
-
Beijing, Beijing, ChinaPeking University Insititute of Hematology, Peking University Pe
Jun 25, 2022
RWE of 1st Line Treatment With ATO/ATRA for Adult APL
Recruiting
- Promyelocytic Leukemia, Adult Acute
- Evaluation of first line treatment with ATO/ATRA outcome
-
Caba, Argentina
- +1 more
Nov 9, 2021
Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in
Recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +4 more
- Atezolizumab
- Tretinoin
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Apr 27, 2022
AML, MDS, Old Age; Debility Trial in Suzhou (Azacitidine, all trans retinoic acid)
Recruiting
- AML
- +3 more
- Azacitidine
- all trans retinoic acid
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Dec 27, 2021
Promyelocytic Leukemia Trial in Monterrey (Arsenic trioxide, all-trans retinoic acid)
Recruiting
- Promyelocytic Leukemia
- Arsenic trioxide
- all-trans retinoic acid
-
Monterrey, Nuevo Leon, MexicoHopsital Universitario Dr. Jose E. Gonzalez, Centro Universitari
Aug 9, 2022
Acute Promyelocytic Leukemia Trial in Xi'an (Realgar-Indigo naturalis formula, all-trans retinoic acid, Arsenic trioxide)
Recruiting
- Acute Promyelocytic Leukemia
- Realgar-Indigo naturalis formula
- +3 more
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xi'an Jiaotong University
Aug 31, 2021
Immune Thrombocytopenia Trial in Beijing (Dexamethasone, ATRA)
Completed
- Immune Thrombocytopenia
- Dexamethasone
- ATRA
-
Beijing, Beijing, ChinaPeking University Insititute of Hematology, Peking University Pe
Sep 22, 2021
Multiple Myeloma Trial in Hackensack (Daratumumab, Pomalidomide, All-trans retinoic acid)
Recruiting
- Multiple Myeloma
- Daratumumab
- +3 more
-
Hackensack, New JerseyJohn Theurer Cancer Center
Jun 10, 2022
Acne Vulgaris Trial in High Point (S6G5T-3, S6G5T-8)
Completed
- Acne Vulgaris
-
High Point, North CarolinaDermatology Consulting Services
Dec 14, 2021
Healthy Trial in Secaucus (HF1K16, Placebo)
Terminated
- Healthy
- HF1K16
- Placebo
-
Secaucus, New JerseyFrontage Clinical Services, Inc.
May 18, 2022
Cholangitis, Sclerosing Trial in New Haven (All-trans retinoic acid)
Terminated
- Cholangitis, Sclerosing
- All-trans retinoic acid
-
New Haven, ConnecticutYale University
Aug 4, 2021
Acute Myeloid Leukemia Trial in Regensburg (low-dose Azacitidine, Pioglitazone, ATRA)
Terminated
- Acute Myeloid Leukemia
- low-dose Azacitidine
- +3 more
-
Regensburg, GermanyUniversity Hospital Regensburg
Nov 3, 2020
APL Trial in Valencia (Atra, Idarubicin, methotrexate)
Recruiting
- APL
- Atra
- +2 more
-
Valencia, SpainHospital La Fe
Mar 22, 2021